Yttrium-90 Microsphere Radioembolization for Treatment of Lung Cancer Hepatic Metastases

Because stage 4 lung cancer is associated with dismal 5-year survival rates, new treatment approaches targeting extrapulmonary disease are necessary. Yttrium-90 microsphere radioembolization is an emerging treatment for metastatic hepatic malignancies that results in high tumor response rates and ex...

Descripción completa

Detalles Bibliográficos
Autores principales: Gaba, Ron C., Lakhoo, Janesh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2012
Materias:
Published online: August, 2012
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3457031/
https://www.ncbi.nlm.nih.gov/pubmed/23109925
http://dx.doi.org/10.1159/000342706

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3457031/
https://www.ncbi.nlm.nih.gov/pubmed/23109925
http://dx.doi.org/10.1159/000342706

Ejemplares similares